H&R GmbH & Co. KGaA (2HRA) Stock Price & Analysis
2HRA Stock Chart & Stats
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- CHF 240.25M
- Enterprise Value
- CHF 327.60M
- Total Cash (Recent Filing)
- CHF 69.45M
- Total Debt (Recent Filing)
- CHF 166.07M
- Price to Earnings (P/E)
- 11.1
- Beta
- -0.17
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 1.46%
Bulls Say, Bears Say
Bulls Say
Specialty Product Diversification
The company serves multiple industrial and consumer-related applications with high-value hydrocarbon products, reducing reliance on any single end market. This diversified specialty portfolio can support customer relevance and provide a more durable revenue base than dependence on one product or application.
Operational Recovery
The rebound in revenue and operating margin shows that the business has regained profitability after a weak 2025. If maintained, stronger operating performance can improve internal funding capacity, reinforce resilience, and provide a better base for earnings over the next several quarters.
Sizable Equity Base
A substantial equity base provides financial support for ongoing operations and reduces dependence on borrowing relative to a more highly leveraged structure. Although debt has increased, the balance sheet remains described as serviceable, giving the company some capacity to manage its business through normal fluctuations.
Bears Say
Very Thin Profitability
The company’s recovery has not yet translated into robust bottom-line profitability. A net margin near zero leaves little room for input, operating, or demand pressures to be absorbed, while the recent loss and earlier stronger results show that earnings power remains volatile rather than consistently durable.
Sharp Free-cash-flow Decline
The steep reduction in free cash flow weakens the quality of the earnings recovery and limits cash available for debt reduction, investment, or shareholder returns. The low conversion rate also indicates that working-capital and capital-expenditure needs can materially reduce the cash benefit of reported profits.
Higher Borrowing Reliance
Increasing leverage raises the company’s reliance on borrowing at a time when returns generated from its equity base remain very low. This combination can constrain financial flexibility and make it harder for balance-sheet resources to produce attractive shareholder returns if earnings remain volatile.
H&R GmbH & Co. KGaA News
2HRA FAQ
What is H&R GmbH & Co. KGaA’s market cap?
When is H&R GmbH & Co. KGaA’s upcoming earnings report date?
How were H&R GmbH & Co. KGaA’s earnings last quarter?
Is H&R GmbH & Co. KGaA overvalued?
Does H&R GmbH & Co. KGaA pay dividends?
What is H&R GmbH & Co. KGaA’s EPS estimate?
How many shares outstanding does H&R GmbH & Co. KGaA have?
What happened to H&R GmbH & Co. KGaA’s price movement after its last earnings report?
Which hedge fund is a major shareholder of H&R GmbH & Co. KGaA?
What is the TipRanks Smart Score and how is it calculated?
H&R GmbH & Co. KGaA Stock Smart Score
Company Description
H&R GmbH & Co. KGaA
H&R GmbH & Co. KGaA is a German enterprise specializing in the production and distribution of chemical-pharmaceutical raw materials and precision plastic components, manufactured through injection molding. The company's operations are structured into three primary segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining division is responsible for manufacturing and supplying a diverse array of refined products, including paraffins, white oils, plasticizers, base oils, lubricants, and other specialized crude oil derivatives, as well as feedstocks and bunker fuels. Concurrently, the ChemPharm Sales segment focuses on the processing and commercialization of products such as plasticizers, wax emulsions, paraffins, and similar crude oil-based specialty items. The Plastics division is dedicated to the development, production, and sale of high-precision plastic parts tailored for industries like medical technology, automotive, and various other sectors. H&R's extensive product portfolio also encompasses petroleum jellies, different types of motor and process oils, cable filling compounds, ozone protection waxes, raw materials for the cosmetic and pharmaceutical sectors, mineral oils, and construction insulation materials. Founded in 1919 and headquartered in Salzbergen, Germany, the company transitioned its name to H&R GmbH & Co. KGaA in August 2016, having previously operated as H&R Aktiengesellschaft. It functions as a subsidiary of H&R Komplementär GmbH.
- Sector
- General
- Industry
- Chemicals - Specialty
- CEO
- Niels H. Hansen
- Employees
- 1,688
- Website
- www.hur.com
- Address
- Neuenkirchener Strasse 8, Salzbergen, NI, 48499, DE

